A freshman seminar encourages students to behave differently in the world and feel more passionately about biodiversity. Each Harvard University freshman in the “Tree” seminar must choose a single ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

The Rockefeller Center Christmas tree was hoisted aloft at its new home in Manhattan on Saturday, marking the start of New York City’s holiday season. This year’s tree is a 75-foot-tall Norway spruce ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

It’s beginning to look a lot like Christmas. Rockefeller Center announced Oct. 27 that its iconic Christmas tree for this year will come from East Greenbush, New York and is being donated by the Russ ...